Clinical Trial Update: A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results on MEDI0382 evaluating its effect on hepatic glycogen metabolism in overweight or obese adults with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• MEDI0382

Snippet

Sponsor: MedImmune LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2024-11-12